ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $987,000 | -62.5% | 24,421 | -46.6% | 0.04% | -52.6% |
| Q2 2015 | $2,633,000 | +707.7% | 45,750 | +794.1% | 0.10% | +691.7% |
| Q1 2015 | $326,000 | +10.1% | 5,117 | -40.5% | 0.01% | +50.0% |
| Q2 2014 | $296,000 | +5.0% | 8,600 | +32.0% | 0.01% | 0.0% |
| Q1 2014 | $282,000 | – | 6,516 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |